Champions Oncology, Inc. (CSBR) Total Assets by Year
Champions Oncology, Inc. closed fiscal year 2026 with $27.0M in total assets, $22.9M in total liabilities and $3.9M in shareholder equity. This represents a decrease of 16.6% from the prior fiscal year. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Champions Oncology, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
CSBR Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2610-K | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $27.0M-16.6% | $32.3M+23.8% | $26.1M-23.8% | $34.3M-3.0% | $35.4M+28.2% | $27.6M+33.0% | $20.8M+84.2% | $11.3M+39.5% | $8.1M+0.8% | $8.0M+38.7% | $5.8M-52.0% | $12.0M+35.9% | $8.9M-23.9% | $11.7M+68.3% | $6.9M |
| Total Liabilities | $22.9M-19.8% | $28.6M+1.9% | $28.0M-5.5% | $29.7M+12.9% | $26.3M+30.3% | $20.2M+28.8% | $15.7M+73.4% | $9.0M+11.8% | $8.1M+6.1% | $7.6M+37.4% | $5.5M+38.9% | $4.0M-29.7% | $5.7M-72.8% | $20.9M+71.0% | $12.2M |
| Total Equity | $3.9M+4.4% | $3.8M+298.2% | -$1.9M-141.0% | $4.6M-49.0% | $9.1M+22.5% | $7.4M+45.7% | $5.1M+138.6% | $2.1M+71133.3% | $3K-99.3% | $400K+68.1% | $238K-97.0% | $8.1M+152.1% | $3.2M+134.7% | -$9.2M-74.4% | -$5.3M |
CSBR Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q1'2710-Q | Q4'2610-Q | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $33.3M+9.0% | $27.0M-16.6% | $28.4M-7.1% | $30.2M+19.5% | $30.5M+22.5% | $32.3M+23.8% | $30.6M+14.3% | $25.2M-10.8% | $24.9M-16.6% | $26.1M-23.8% | $26.8M-25.9% | $28.3M-22.2% |
| Total Liabilities | $28.8M+6.7% | $22.9M-19.8% | $24.1M-4.3% | $25.9M+5.6% | $27.0M+6.9% | $28.6M+1.9% | $25.2M-12.8% | $24.6M-12.9% | $25.3M-9.8% | $28.0M-5.5% | $28.8M-0.8% | $28.2M+3.7% |
| Total Equity | $3.9M+11.0% | $3.9M+4.4% | $4.3M-21.7% | $4.2M+512.3% | $3.5M+1156.6% | $3.8M+298.2% | $5.5M+365.7% | $681K+632.3% | -$332K-117.4% | -$1.9M-141.0% | -$2.1M-129.1% | $93K-99.0% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Champions Oncology, Inc. financials
Frequently Asked Questions
What was Champions Oncology, Inc.'s total assets in fiscal year 2026?
Champions Oncology, Inc. closed fiscal year 2026 with $27.0M in total assets, $22.9M in total liabilities and $3.9M in shareholder equity.
How fast is Champions Oncology, Inc.'s total assets growing?
Champions Oncology, Inc. (CSBR) total assets fell by 16.6% year over year, from $32.3M to $27.0M in fiscal year 2026.
How has Champions Oncology, Inc.'s total assets changed over the years?
Across the 15 fiscal years this page covers, Champions Oncology, Inc. (CSBR) total assets went from $6.9M in fiscal year 2012 to $27.0M in fiscal year 2026.
What was Champions Oncology, Inc.'s total assets in the most recent quarter?
Champions Oncology, Inc. (CSBR) reported $33.3M in total assets in Q1 2027. This represents an increase of 9.0% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Champions Oncology, Inc. (CSBR) reported on that line in every period on record.